Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Effect of Watching a Comedy Video on Anxiety, Pain, Procedural Readiness, and Uroflowmetric Parameters in Patients Undergoing Urodynamic Testing

NCT07728903 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-08-01
Last updated
2026-07-27

Condition(s) studied

Watching a Comedy Video

Investigational drug(s) / intervention(s)

Watching a comedy video

Watching a comedy video: Participants allocated to the intervention group will watch a standardized comedy video for approximately 15 minutes on a tablet computer immediately before the urodynamic procedure under the supervision of researcher EKD. The video will be viewed in the patient's room under the supervision of a healthcare professional. The video material will be preselected by the research team and will include only scenes that do not contain violence, insults, profanity, sexual content, discrimination, or intense conflict that could evoke negative emotional responses in participants. The selection of the video content will also consider cultural appropriateness, comprehensibility, and broad audience appeal. Şahinalp (2010), in a study examining the evolution of Turkish comedy films, reported that comedy films produced during the 1970s elicited stronger humorous responses from audiences than films from later periods. Furthermore, Genç and Sarıtaş (2020) demonstrated that comedy video clips compiled f

Study summary

This study aims to determine the effects of watching a comedy video on anxiety, pain, procedural readiness, and uroflowmetric parameters in patients undergoing urodynamic testing.

Data will be collected using the Descriptive Characteristics Form, State Anxiety Inventory (SAI), Visual Analog Scale (VAS), Procedural Readiness Form, and Uroflowmetric Parameters Monitoring Form.

Upon admission to the urodynamic unit, all participants will complete the Descriptive Characteristics Form, State Anxiety Inventory, and Procedural Readiness Form under the supervision of researcher GB.

Participants assigned to the control group will receive the institution's standard pre-procedural care. As part of routine clinical practice, patients will wait in the designated waiting area until their scheduled procedure time. When called to the urodynamic unit, they will receive the standard pre-procedural information routinely provided by the clinic. Patients will then be asked to remove their clothing and assume the appropriate position for the procedure. Urodynamic catheters will be inserted according to the institutional protocol, and the urodynamic examination will be performed. During the procedure, bladder filling and voiding functions will be evaluated. After completion of the examination, the catheters will be removed, and patients will be discharged according to routine clinical practice.

Participants assigned to the intervention group will watch a 15-minute comedy video on a tablet computer immediately before the urodynamic procedure under the supervision of researcher EKD. The video will be viewed in the patient's room under the supervision of a healthcare professional. The video material will consist of scenes carefully selected by the researchers to exclude violence, insults, profanity, sexual content, discrimination, or intense conflict that might evoke negative emotional responses. The selection of the video content will also consider cultural appropriateness, comprehensibility, and broad public appeal.

Short humorous scenes without negative content will be selected from popular 1970s Turkish comedy films starring Kemal Sunal, including Erkek Güzeli Sefil Bilo, İnek Şaban, Hababam Sınıfı, and similar productions. These clips will be compiled into a single standardized video lasting approximately 15 minutes, and all participants in the intervention group will watch the same video in the same sequence.

During the urodynamic procedure, uroflowmetric parameters will be recorded in the Uroflowmetric Parameters Monitoring Form by researcher GB.

Immediately after completion of the procedure, procedural pain will be assessed using the Visual Analog Scale (VAS), which will be administered by researcher GB.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Aged 18 years or older. * Scheduled to undergo urodynamic testing for the first time. * Conscious, oriented, and able to cooperate. * Able to provide written informed consent. * Able to speak and understand Turkish. * Without any physical or cognitive disability that would interfere with participation in the study. Exclusion Criteria: * Declining to participate or withdrawing from the study at any stage. * Having chronic pain. * Currently using anxiolytic medication.

Primary outcome measure(s)

  • Pain Level — 12 months
    This scale allows patients to evaluate their level of pain on a line ranging from 0 (no pain) to 10 (extremely severe pain). It will be used to assess the intensity of pain experienced by the patients.
  • Uroflowmetric Parameters — 12 months
    During the procedure, the maximum flow rate (Qmax) will be recorded.
  • Anxiety — 12 months
    It is designed to assess an individual's current emotional state by asking them to respond according to how they feel at that moment.
  • Procedural Readiness — 12 months
    This scale allows patients to evaluate their level of Procedural Readiness on a line ranging from 0 (no Procedural Readiness) to 10 (extremely severe Procedural Readiness). It will be used to assess the intensity of Procedural Readiness experienced by the patients.
  • Uroflowmetric Parameters — 12 months
    During the procedure, the mean flow rate (Qavg) will be recorded.
  • Uroflowmetric Parameters — 12 months
    During the procedure, voiding time will be recorded.

Trial sites (1)

FacilityCityRegionStatus
Tarsus University Mersin Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07728903 on ClinicalTrials.gov ↗ ← All trials in Turkey